There’s been a flurry of activity on the Chinese vaccine distribution front. Over the weekend, a growing number of countries across the Global South are taking delivery of Chinese-made COVID-19 vaccines even before they completed clinical trials or received WHO pre-qualification.
These countries, many in the Middle East, South America, and Asia, are all becoming increasingly concerned that they’re going to be left behind in gaining access to vaccines due to widespread vaccine hoarding by wealthier countries.
Lead the Conversation on China
Subscribe Today to Get Full Access to The China-Global South Project
The China-Global South Daily Brief delivered to your inbox at 6AM Washington time
Full access to exclusive news and analysis from editors based in the Global South
Transcripts of CGSP’s twice-weekly podcasts